An aim of this study is to describe quantitatively and qualitatively progression and findings from the HTA topic selection process recently developed by HITAP. The process involves potential users of HTA information; namely (1) third party payers (public health insurers), (2) national health care program managers (Ministry of Public Health’s Depa

The Health Intervention and Technology Assessment Program (HITAP) was established in 2007 as a non-profit organization. Its main responsibility is to assess health interventions and technology assessment with the coverage of pharmaceuticals, medical devices, interventions, individual and community health promotions and disease prevention, as well a

Vaccines have been a game-changer in the fight against COVID-19. Yet, vaccine hesitancy has impeded its uptake, impacting public health efforts. At the outset of the pandemic, people had doubts about this unfamiliar virus and subsequently, the vaccine: misinformation, rumours, and doubts about COVID

To learn how best to prescribe powerful drugs to children, Congress passed a law in the 1990s that rewarded drug makers for conducting clinical studies involving children. Among the incentives for cooperating companies was a possible six-month extension of protection from generic competition after a

(Reuters) – GlaxoSmithKline is holding talks this weekend with Human Genome Sciences to agree a deal to acquire it for some $2.6 billion, after pursuing the U.S. biotech company for three months, sources familiar with the situation said on Sunday.The British pharmaceutical giant could sweeten its pr

PMAC 2016 Side Event (SE 014): Advanced Workshop in Methods for HTAThe methods of HTA have developed rapidly in the last decade. This is particularly the case in assessing the cost-effectiveness of interventions using modelling methods and in undertaking uncertainty analysis to guide decisions. Deci

(Reuters) – A U.S. Food and Drug Administration panel on Thursday recommended two drugs for combating different forms of vision loss that can lead to blindness among a range of adults, including diabetics and the elderly.The FDA advisory committee of outside experts gave its support to Swiss-based R

The abundance of various innovations in healthcare (pharmaceuticals, medical devices, interventions, individual and community health promotion and disease prevention as well as a social health policy) have been continuously used in the healthcare system, resulting in a higher demand for resources and budgets in disease prevention and healthcare. Th

(Reuters) – Scientists have grown a drug to treat a rare genetic disease inside corn plants, potentially offering a cheaper way to manufacture a treatment that currently costs hundreds of thousands of dollars a year for each patient.The move marks an advance for the emerging field of molecular farmi

Nonthaburi, Thailand | November 25, 2022 – The Health Intervention and Technology Assessment Program (HITAP) announced the completion of the first Technical Workshop on Infectious Disease Modelling. Research staff from the London School of Hygiene and Tropical Medicine (LSHTM) with joint appointment